| Reactive astrocyte nomenclature, definitions, and future directions C Escartin, E Galea, A Lakatos, JP O’Callaghan, GC Petzold, ... Nature neuroscience 24 (3), 312-325, 2021 | 1809 | 2021 |
| Neuroendocrine aspects of the response to stress DB Miller, JP O'Callaghan Metabolism-Clinical and Experimental 51 (6), 5-10, 2002 | 748 | 2002 |
| DARPP-32: regulator of the efficacy of dopaminergic neurotransmission AA Fienberg, N Hiroi, PG Mermelstein, WJ Song, GL Snyder, A Nishi, ... Science 281 (5378), 838-842, 1998 | 622 | 1998 |
| Work, obesity, and occupational safety and health PA Schulte, GR Wagner, A Ostry, LA Blanciforti, RG Cutlip, KM Krajnak, ... American journal of public health 97 (3), 428-436, 2007 | 546 | 2007 |
| Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. JP O'Callaghan, DB Miller Journal of Pharmacology and Experimental Therapeutics 270 (2), 741-751, 1994 | 489 | 1994 |
| Biomarkers of Parkinson’s disease: present and future DB Miller, JP O’Callaghan Metabolism 64 (3), S40-S46, 2015 | 475 | 2015 |
| Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease K Sriram, JM Matheson, SA Benkovic, DB Miller, MI Luster, ... The FASEB journal 16 (11), 1474-1476, 2002 | 466 | 2002 |
| Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment RF White, L Steele, JP O'Callaghan, K Sullivan, JH Binns, BA Golomb, ... Cortex 74, 449-475, 2016 | 447 | 2016 |
| Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. JP O'Callaghan, SG Holtzman Journal of Pharmacology and Experimental Therapeutics 192 (3), 497-505, 1975 | 372 | 1975 |
| Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1, 2 … K Sriram, SA Benkovic, MA Hebert, DB Miller, JP O'Callaghan Journal of biological chemistry 279 (19), 19936-19947, 2004 | 363 | 2004 |
| Astrogliosis in CNS pathologies: is there a role for microglia? D Zhang, X Hu, L Qian, JP O’Callaghan, JS Hong Molecular neurobiology 41, 232-241, 2010 | 359 | 2010 |
| The impact of gender and estrogen on striatal dopaminergic neurotoxicity DB Miller, SF Ali, JP O'CALLAGHAN, SC Laws Annals of the New York Academy of Sciences 844 (1), 153-165, 1998 | 331 | 1998 |
| Environment-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. DB Miller, JP O'Callaghan Journal of Pharmacology and Experimental Therapeutics 270 (2), 752-760, 1994 | 326 | 1994 |
| Divergent roles for tumor necrosis factor-α in the brain K Sriram, JP O’Callaghan Journal of Neuroimmune Pharmacology 2, 140-153, 2007 | 317 | 2007 |
| Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum A Nishi, M Kuroiwa, DB Miller, JP O'Callaghan, HS Bateup, T Shuto, ... Journal of Neuroscience 28 (42), 10460-10471, 2008 | 308 | 2008 |
| Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+ APP mouse MN Gordon, LA Holcomb, PT Jantzen, G DiCarlo, D Wilcock, KW Boyett, ... Experimental neurology 173 (2), 183-195, 2002 | 304 | 2002 |
| Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-α K Sriram, JM Matheson, SA Benkovic, DB Miller, MI Luster, ... | 292 | 2006 |
| Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced … TO Brock, JP O'callaghan Journal of Neuroscience 7 (4), 931-942, 1987 | 286 | 1987 |
| Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity JP O’Callaghan, K Sriram Expert opinion on drug safety 4 (3), 433-442, 2005 | 284 | 2005 |
| Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α K Sriram, DB Miller, JP O'Callaghan Journal of neurochemistry 96 (3), 706-718, 2006 | 282 | 2006 |
Kimberly KellyCenters for Disease Control and PreventionVerified email at cdc.gov